Since IL22 was found mainly produced by CD4+T cells in tumor-bearing lung tissues, with a key role in modulation of pro-tumor inflammatory responses in lung cancer20, our results suggest the probability of IL22 expression being related to dysfunction of tumor-related CD4+T cells in CM. This evidence concerns the gene CD4 and neoplasm.